Pancreatic Cancer Research

ResearcherCentral South UniversityActive in the last 2 years

Yuqiang Li

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-1517-3687; OpenAlex author ID A5100697806. Sources: OpenAlex.

Their work

Papers
9 (first author 1, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
15
Papers, trials and grants by year

2015: 1 paper · 2016: none · 2017: none · 2018: none · 2019: none · 2020: 2 papers · 2021: 2 papers · 2022: 3 papers · 2023: none · 2024: none · 2025: 1 paper

Papers 9

  1. Development of a hypoxia-responsive macrophage prognostic model using single-cell and bulk RNA sequencing in pancreatic cancer. Co-author DOI 10.1371/journal.pone.0322618↗
  2. The Survival Effect of Radiotherapy on Stage IIB/III Pancreatic Cancer Undergone Surgery in Different Age and Tumor Site Groups: A Propensity Scores Matching A… Co-author DOI 10.3389/fonc.2022.799930↗
  3. The Extracellular Matrix: A Key Accomplice of Cancer Stem Cell Migration, Metastasis Formation, and Drug Resistance in PDAC. First author DOI 10.3390/cancers14163998↗
  4. The survival impact of palliative radiotherapy on synchronous metastatic pancreatic ductal adenocarcinoma: metastatic site can serve for radiotherapy-decision. Co-author DOI 10.7150/jca.64800↗
  5. m6A Methyltransferase METTL14-Mediated Upregulation of Cytidine Deaminase Promoting Gemcitabine Resistance in Pancreatic Cancer. Last author DOI 10.3389/fonc.2021.696371↗
  6. A novel risk-scoring system conducing to chemotherapy decision for patients with pancreatic ductal adenocarcinoma after pancreatectomy. Co-author DOI 10.7150/jca.57768↗
  7. Effect of neoadjuvant radiotherapy on survival of non-metastatic pancreatic ductal adenocarcinoma: a SEER database analysis. Last author DOI 10.1186/s13014-020-01561-z↗
  8. The Main Bottleneck for Non-Metastatic Pancreatic Adenocarcinoma in Past Decades: A Population-Based Analysis. Co-author DOI 10.12659/msm.921515↗
  9. Mutated K-ras activates CDK8 to stimulate the epithelial-to-mesenchymal transition in pancreatic cancer in part via the Wnt/β-catenin signaling pathway. Co-author DOI 10.1016/j.canlet.2014.10.008↗

Closest collaborators

The 15 strongest of 15 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Cenap Güngör · 7 shared papers, 2020–2025 · strength 1.16
  2. Heming Ge · 3 shared papers, 2022–2025 · strength 0.67
  3. Dan Wang · 3 shared papers, 2020–2022 · strength 0.44
  4. Gerrit Wolters‐Eisfeld · 1 shared paper, 2025 · strength 0.33
  5. Thilo Hackert · 1 shared paper, 2025 · strength 0.33
  6. Dan Wang · 2 shared papers, 2021–2022 · strength 0.27
  7. Matthias Reeh · 1 shared paper, 2022 · strength 0.19
  8. Tarik Ghadban · 1 shared paper, 2022 · strength 0.19
  9. Biaoxiang Xu · 1 shared paper, 2022 · strength 0.15
  10. Zhongyi Zhou · 1 shared paper, 2022 · strength 0.15
  11. Congjun Zhang · 1 shared paper, 2021 · strength 0.14
  12. Christine Nitschke · 1 shared paper, 2021 · strength 0.12
  13. Wei Zhang · 1 shared paper, 2015 · strength 0.05
  14. Wei Xu · 1 shared paper, 2015 · strength 0.05
  15. Yu-Cheng Tang · 1 shared paper, 2015 · strength 0.05

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.